CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $426K invested in Cellectar Biosciences in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

16% less capital invested

Capital invested by funds: $505K → $426K (-$78.7K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$59K
2
+$44K
3
+$35K
4
IGGA
Iron Gate Global Advisors
Utah
+$9.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.87K

Top Sellers

1
-$18K
2
-$1.82K
3
-$1K
4
BlackRock
BlackRock
New York
-$1K
5
APA
American Portfolios Advisors
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$153K
2
$59K
3
$44K
4
$35K
5
$34K
6
$20K
7
$19K
8
$19K
9
$18K
10
$18K
11
$3K
12
$3K
13
$1K
14
$1
15
–
16
–